Durability of VEGF Suppression With Intravitreal Aflibercept and Brolucizumab: Using Pharmacokinetic Modeling to Understand Clinical Outcomes
Translational Vision Science & Technology | April 14, 2021 | Volume: 10 | Issue: 4 | Pages: 9
10.1167/tvst.10.4.9
| PMID 34003985